« Back to Record
Citation APA

Oyharcabal-Bourden, V., Kalifa, C., Gentet, J. C., Frappaz, D., Edan, C., Chastagner, P., Sariban, E., Pagnier, A., Babin, A., Pichon, F., Neuenschwander, S., Vinchon, M., Bours, D., Mosseri, V., Le Gales, C., Ruchoux, M.-M., Carrie, C., & Doz, F. (2005). Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. Journal of clinical oncology, 23(21), 4726-4734. doi:10.1200/JCO.2005.00.760


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/51619

Oyharcabal-Bourden, V., Kalifa, C., Gentet, J. C., Frappaz, D., Edan, C., Chastagner, P., Sariban, E., Pagnier, A., Babin, A., Pichon, F., Neuenschwander, S., Vinchon, M., Bours, D., Mosseri, V., Le Gales, C., Ruchoux, M.-M., Carrie, C., & Doz, F. (2005). Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. Journal of clinical oncology, 23(21), 4726-4734. doi:10.1200/JCO.2005.00.760